Press Releases
August 24, 2021•News, Press Releases
The First Survivors of Alzheimer’s by Dr. Dale Bredesen Now Available
Apollo Health announces the release of Dr. Dale Bredesen's book "The First Survivors of Alzheimer's," featuring seven survivors who tell their stories of moving from hopelessness to health and succeeding in their efforts to reverse their cognitive decline. Read More »
July 1, 2021•News, Press Releases
Scientific Breakthrough in Alzheimer’s is Here
Apollo Health announces a scientific breakthrough with the recent clinical validation of the ReCODE Protocol designed to reverse cognitive decline and bring relief to millions who suffer from dementia. Read More »
May 13, 2021•News, Press Releases
Trial First to Show Improvements in Alzheimer’s Patients
Apollo Health Announces Results of the study by Drs. Dale Bredesen, Kat Toups, Anne Hathaway, and Deborah Gordon, "Precision Medicine Approach to Alzheimer's Disease: Successful Proof-of-Concept Trial," that provides evidence of improvement in early stages of Alzheimer's. Read More »
November 11, 2020•News, Press Releases
Amidst the Pandemic, Apollo Health Launches PreCODE to Protect Cognition
As the country prepares for an uptick in COVID-19 cases, the PreCODE Program has arrived just in time to help deal with the challenges conferred by the pandemic. Read More »
March 4, 2019•News, Press Releases
LifeSeasons is proud to introduce ReCODE Protocol, a new line of cognitive support supplements formulated with the world-renowned neurologist and author of the New York Times bestseller, The End of Alzheimer's, Dale Bredesen, MD. Read More »
July 26, 2018•News, Press Releases
AHNP Precision Health Launches the ReCODE Report®
Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of The Bredesen Protocol, AHNP Precision Health has launched the US version of the ReCODE Report, a proprietary implementation of the Bredesen Protocol which allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Read More »
July 6, 2018•News, Press Releases
AHNP Precision Health Acquires MPI Cognition Dementia Business
AHNP Precision Health is announcing its acquisition of the MPI Cognition dementia business in order to rapidly bring a ground-breaking Alzheimer's treatment protocol designed by the leading Alzheimer's researcher to the market. Dale Bredesen MD, Founder, Co-Chairman, and Chief Science Officer of MPI Cognition is the best-selling author of the highly-acclaimed book, The End of Alzheimer’s. Read More »